Fetal brain diffusion MRI in growth-restricted pregnancies
Official title: COMPARISON OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING FINDINGS IN FETUSES WITH AND WITHOUT FETAL GROWTH RESTRICTION: THE IMPACT OF MIDDLE CEREBRAL ARTERY DOPPLER FINDINGS
Run by Istanbul Training and Research Hospital · NCT07769957 · Data updated 2026-11-12
This study tests whether diffusion-weighted MRI can reveal differences in fetal brain tissue in growth-restricted pregnancies versus healthy pregnancies, using MCA Doppler patterns to help interpret the findings.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Istanbul Training and Research Hospital Government |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | March 26, 2026 |
| Main results expected | December 2029 |
| Study ends | December 2030 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT07769957 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Candidates are pregnant individuals with singleton gestations between 28 and 38 weeks, including those with FGR (EFW or AC below the 10th percentile) and healthy controls (EFW/AC between the 10th and 90th percentiles) with normal Doppler and no major anomalies.
✕Probably not a fit
Pregnancies not meeting the imaging or Doppler criteria, or with contraindications to MRI, may not derive direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study compares regional brain diffusion measurements from diffusion-weighted MRI in fetuses with fetal growth restriction (FGR) to those in appropriately grown fetuses. Fetuses are grouped by FGR with normal MCA Doppler, FGR with MCA Doppler redistribution, and healthy controls with normal Doppler. MRI is performed at 1.5 Tesla, and fractional regions such as frontal, occipital, temporal white matter, thalamus, pons, cerebellum, and centrum semiovale are analyzed for apparent diffusion coefficient values. The primary aim is to identify differences in regional ADC values between FGR and controls; a secondary aim considers the relationship between MCA Doppler findings and ADC patterns. This is an observational, non-interventional study designed to explore potential brain diffusion changes associated with FGR.
Why it matters
Potential benefit: If successful, the findings could improve understanding of fetal brain changes in FGR and guide future diagnostics or monitoring strategies.
How similar studies have gone: Past work in fetal MRI has demonstrated the feasibility of diffusion measurements, though this study focuses on correlating diffusion with Doppler patterns in FGR.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Singleton pregnancy * Gestational age between 28 and 38 weeks * Maternal age between 18 and 45 years * For the FGR groups: estimated fetal weight (EFW) below the 10th percentile and/or abdominal circumference (AC) below the 10th percentile * For the control group: EFW and AC between the 10th and 90th percentiles, normal fetal Doppler findings, and no major structural anomaly on fetal anatomical examination * Written informed consent for participation in the study Exclusion Criteria: * Multiple pregnancy * Major fetal structural anomaly or diagnosed chromosomal abnormality * Contraindication to MRI, such as an MRI-incompatible implant * Maternal uncontrolled diabetes mellitus, significant thyroid disease, severe uncontrolled chronic hypertension, or other significant systemic chronic disease * Maternal age below 18 or above 45 years * Inability or unwillingness to provide informed consent or cooperate with study procedures
Where it's running
-
Istanbul Training and Research Hospital Department of Obstetrics and Gynecology
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Doruk C Katlan
- Email: dcek2000@yahoo.com
- Phone: +905353475411
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging
This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.
-
AI-based ultrasound and MRI to predict outcomes in placental-related fetal growth restriction
This project will test whether combining AI analysis of ultrasound and MRI with standard fetal monitoring can predict short- and long-term outcomes for pregnancies affected by early-onset, placental-related fetal growth restriction.
-
How the placenta affects maternal and fetal health
This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.
-
Amniotic fluid and the extremely preterm baby's gut
We will see if amniotic fluid from extremely preterm births (24+0 to 27+6 weeks) shows changes that relate to gut problems such as necrotizing enterocolitis or sepsis in very preterm infants.
-
Examining how assisted reproductive technologies affect pregnancy outcomes
This study is trying to see if different assisted reproductive technologies affect the health of pregnancies and if they are linked to risks like growth problems or stillbirth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.